Disc Medicine (NASDAQ: IRON) director Nadim Ahmed awarded 5,176 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Disc Medicine director Nadim Ahmed received a grant of stock options, giving him the right to buy 5,176 shares of common stock. The options have an exercise price of $70.79 per share and expire on June 17, 2036.
These options vest on the earlier of the company’s 2027 annual stockholders’ meeting or the one-year anniversary of the grant date, contingent on his continued board service. After this grant, Ahmed holds options covering 5,176 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
AHMED NADIM
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,176 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,176 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 5,176 shares
Exercise price: $70.79 per share
Expiration date: June 17, 2036
+1 more
4 metrics
Options granted
5,176 shares
Stock Option (Right to Buy) grant to director
Exercise price
$70.79 per share
Exercise price of granted stock options
Expiration date
June 17, 2036
Option expiration for this grant
Post-grant option holdings
5,176 options
Total options reported following transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, annual meeting of its stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 70.7900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-17T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting of its stockholders financial
"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders"
vest financial
"The shares underlying this option vest upon the first to occur"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did Disc Medicine (IRON) director Nadim Ahmed receive in this Form 4 filing?
Director Nadim Ahmed received a grant of stock options covering 5,176 shares of Disc Medicine common stock, with an exercise price of $70.79 per share and an expiration date of June 17, 2036, according to the Form 4 disclosure.
At what price can Nadim Ahmed exercise his Disc Medicine (IRON) stock options?
The stock options granted to Nadim Ahmed are exercisable at $70.79 per share. This exercise price is fixed in the award and applies to all 5,176 underlying shares of Disc Medicine common stock disclosed in the Form 4.
When do Nadim Ahmed’s Disc Medicine (IRON) stock options vest?
The options vest on the earlier of Disc Medicine’s 2027 annual stockholders’ meeting or the one-year anniversary of the grant date. Vesting is conditioned on Ahmed’s continued service as a director through that vesting date, as described in the footnote.
How many Disc Medicine (IRON) options does Nadim Ahmed hold after this transaction?
After this grant, Nadim Ahmed beneficially holds stock options for 5,176 shares of Disc Medicine common stock. The Form 4 shows these options as directly owned and reflects the post-transaction total for this specific award.